都

都凯

Insider activity · 24 months0 buys1 saleCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€4,499

Latest filing published 01 Sept 2026 for 甘李药业, €4,499.

Filing timeline

BuySale

都凯

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

都凯: trading record in brief

One trade, one date: on 1 September 2026, 都凯 disclosed an open-market sale of €4,499 in 甘李药业. No broader history exists yet. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 都凯

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

甘李药业 (CN)

Declarations1 total

▼
都凯
董事,高级管理人员Executives1 Sept 2026甘李药业
35,100 CNY15SSE
500 shares@ CN¥547.6586100.0% of flowA股XSHGSSE:273000001434740670

1 of 1 declaration

都凯

Insider track record

都凯: trading record in brief

Companies and markets linked to 都凯

Related entities